84999-030 NDC - SCHUESSLER TISSUE SALTS COMB 12 GENERAL TONIC (CALCAREA FLUORICA,CALCAREA PHOSPHORICA,CALCAREA SULPHURICA,FERRUM PHOSPHORICUM ,KALI PHOSPHORICUM,KALI MURIATICUM,KALI SULPHURICUM,MAGNESIA PHOSPHORICA,NATRUM MURIATICUM,NATRUM PHOSPHORICUM,NATRUM SULPHURICUM,SILICEA)

Drug Information

  • Product NDC: 84999-030
  • Proprietary Name: Schuessler Tissue Salts Comb 12 General Tonic
  • Non Proprietary Name: Calcarea Fluorica,Calcarea Phosphorica,Calcarea Sulphurica,Ferrum Phosphoricum ,Kali Phosphoricum,Kali Muriaticum,Kali Sulphuricum,Magnesia Phosphorica,Natrum Muriaticum,Natrum Phosphoricum,Natrum Sulphuricum,Silicea
  • Active Ingredient(s): 6 [hp_X]/30mL CALCIUM FLUORIDE; 6 [hp_X]/30mL CALCIUM SULFATE DIHYDRATE; 6 [hp_X]/30mL DIBASIC POTASSIUM PHOSPHATE; 6 [hp_X]/30mL FERROUS PHOSPHATE; 6 [hp_X]/30mL MAGNESIUM PHOSPHATE, DIBASIC; 6 [hp_X]/30mL POTASSIUM CHLORIDE; 6 [hp_X]/30mL POTASSIUM SULFATE; 6 [hp_X]/30mL SILICON DIOXIDE; 6 [hp_X]/30mL SODIUM CHLORIDE; 6 [hp_X]/30mL SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; 6 [hp_X]/30mL SODIUM SULFATE ANHYDROUS; 6 [hp_X]/30mL TRIBASIC CALCIUM PHOSPHATE
  • Administration Route(s): ORAL
  • Dosage Form(s): SPRAY
  • Pharmacy Class(es): Blood Coagulation Factor [EPC]; Calcium [CS]; Cations; Divalent [CS]; Increased Coagulation Factor Activity [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Potassium Compounds [CS]; Potassium Compounds [CS]; Potassium Salt [EPC]; Potassium Salt [EPC]

Labeler Information

Field Name Field Value
Labeler Name: Martin & Pleasance Pty Ltd
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:8/1/2025

Package Information

No. Package Code Package Description Billing Unit
184999-030-011 BOTTLE, SPRAY in 1 CARTON (84999-030-01) / 30 mL in 1 BOTTLE, SPRAY

NDC Record

Field Name Field Value Definition
PRODUCT NDC84999-030The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMESchuessler Tissue Salts Comb 12 General TonicThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMECalcarea Fluorica,Calcarea Phosphorica,Calcarea Sulphurica,Ferrum Phosphoricum ,Kali Phosphoricum,Kali Muriaticum,Kali Sulphuricum,Magnesia Phosphorica,Natrum Muriaticum,Natrum Phosphoricum,Natrum Sulphuricum,SiliceaThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMESPRAYThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE8/1/2025This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEMartin & Pleasance Pty LtdName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMECALCIUM FLUORIDE; CALCIUM SULFATE DIHYDRATE; DIBASIC POTASSIUM PHOSPHATE; FERROUS PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM SULFATE ANHYDROUS; TRIBASIC CALCIUM PHOSPHATEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6 
ACTIVE INGRED UNIT[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL 
PHARM CLASSESBlood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 11/21/2025